Fiche personne


Territoire

Bourgogne

Statut

Enseignant-Chercheur

Projets


Voir plus

Publications


Combining PD-L1 blockade with a second-generation HSP110 inhibitor enhances antitumor immunity in colorectal cancer.

Abrey-Recalde MJ, Mialhe F, Le TK, Radoua A, Lagorgette L, Belkaid R, Mamode Cassim A, Gonzalez D, Jacquin E, Gobbo J, Bibeau F, Lepage C, Xu L, He X, Derangère V, Lirussi F, Jego G, Ye XY, Hermetet F, Garrido C

Cell Death Dis. 2026 05 19;:

First-in-class inhibitor of HSP110 blocks BCR activation through SYK phosphorylation in diffuse large B-cell lymphoma.

Gibouin VC, Durand M, Boudesco C, Hermetet F, Nozickova K, Chassagne-Clement C, Abdelwahed M, Klener P, Garrido C, Jego G

Leukemia. 2024 06 21;:

A first-in-class inhibitor of HSP110 to potentiate XPO1-targeted therapy in primary mediastinal B-cell lymphoma and classical Hodgkin lymphoma.

Durand M, Cabaud Gibouin V, Duplomb L, Salmi L, Caillot M, Sola B, Camus V, Jardin F, Garrido C, Jego G

J Exp Clin Cancer Res. 2024 05 22;43(1):148

Voir plus